Cargando…
The selective TrkA agonist, gambogic amide, promotes osteoblastic differentiation and improves fracture healing in mice
OBJECTIVES: To study effects of the selective TrkA agonist, gambogic amide (GA), on fracture healing in mice and on an osteoprogenitor cell line in vitro. METHODS: Mice were given bilateral fibular fractures and treated for two weeks with vehicle or 1 mg/kg/day GA and euthanized at 14-, 21-, and 42-...
Autores principales: | Johnstone, Maddison R., Brady, Rhys D., Schuijers, Johannes A., Church, Jarrod E., Orr, David, Quinn, Julian M.W., McDonald, Stuart J., Grills, Brian L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Musculoskeletal and Neuronal Interactions
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454248/ https://www.ncbi.nlm.nih.gov/pubmed/30839307 |
Ejemplares similares
-
The TrkB agonist, 7,8-dihydroxyflavone, impairs fracture healing in mice
por: Johnstone, Maddison R., et al.
Publicado: (2021) -
Effects of the selective TrkA agonist gambogic amide on pigmentation and growth of human hair follicles in vitro
por: Campiche, Remo, et al.
Publicado: (2019) -
Gambogic amide inhibits angiogenesis by suppressing VEGF/VEGFR2 in endothelial cells in a TrkA-independent manner
por: Sui, Tongtong, et al.
Publicado: (2021) -
TrkA Co-Receptors: The Janus Face of TrkA?
por: Trouvilliez, Sarah, et al.
Publicado: (2023) -
Gambogic acid protects LPS-induced apoptosis and inflammation in a cell model of neonatal pneumonia through the regulation of TrkA/Akt signaling pathway
por: Gao, Xu, et al.
Publicado: (2021)